β-Arrestin-1 Competitively Inhibits Insulin-Induced Ubiquitination and Degradation of Insulin Receptor Substrate 1

REFERENCES

• Barak, L. S., Ferguson S. S., Zhang J., and Caron M. G.. 1997. A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J. Biol. Chem. 272:27497–27500.
   PubMed Web of Science ®Google Scholar
• Bonifacino, J. S., and Weissman A. M.. 1998. Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell. Dev. Biol. 14:19–57.
   PubMed Web of Science ®Google Scholar
• Ciechanover, A. 1998. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17:7151–7160.
   PubMed Web of Science ®Google Scholar
• Dalle, S., Imamura T., Rose D. W., Worrall D. S., Ugi S., Hupfeld C. J., and Olefsky J. M.. 2002. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1. Mol. Cell. Biol. 22:6272–6285.
   PubMed Web of Science ®Google Scholar
• Dalle, S., Ricketts W., Imamura T., Vollenweider P., and Olefsky J. M.. 2001. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276:15688–15695.
   PubMedGoogle Scholar
• DeFea, K. A., Vaughn Z. D., O'Bryan E. M., Nishijima D., Dery O., and Bunnett N. W.. 2000. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc. Natl. Acad. Sci. USA 97:11086–11091.
   PubMed Web of Science ®Google Scholar
• DeFea, K. A., Zalevsky J., Thoma M. S., Dery O., Mullins R. D., and Bunnett N. W.. 2000. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148:1267–1281.
   PubMed Web of Science ®Google Scholar
• Fang, S., Jensen J. P., Ludwig R. L., Vousden K. H., and Weissman A. M.. 2000. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275:8945–8951.
   PubMed Web of Science ®Google Scholar
• Haruta, T., Uno T., Kawahara J., Takano A., Egawa K., Sharma P. M., Olefsky J. M., and Kobayashi M.. 2000. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 14:783–794.
   PubMed Web of Science ®Google Scholar
• Hershko, A., and Ciechanover A.. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425–479.
   PubMed Web of Science ®Google Scholar
• Honda, R., Tanaka H., and Yasuda H.. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25–27.
   PubMed Web of Science ®Google Scholar
• Hupfeld, C. J., Dalle S., and Olefsky J. M.. 2003. Beta-arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Gα s signaling in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 100:161–166.
   PubMed Web of Science ®Google Scholar
• Imamura, T., Huang J., Dalle S., Ugi S., Usui I., Luttrell L. M., Miller W. E., Lefkowitz R. J., and Olefsky J. M.. 2001. Beta-arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J. Biol. Chem. 276:43663–43667.
   PubMed Web of Science ®Google Scholar
• Imamura, T., Vollenweider P., Egawa K., Clodi M., Ishibashi K., Nakashima N., Ugi S., Adams J. W., Brown J. H., and Olefsky J. M.. 1999. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol. Cell. Biol. 19:6765–6774.
   PubMed Web of Science ®Google Scholar
• Kirschner, M. 1999. Intracellular proteolysis. Trends Cell Biol. 9:M42–M45.
   PubMedGoogle Scholar
• Kornitzer, D., and Ciechanover A.. 2000. Modes of regulation of ubiquitin-mediated protein degradation. J. Cell. Physiol. 182:1–11.
   PubMed Web of Science ®Google Scholar
• Lin, F. T., Krueger K. M., Kendall H. E., Daaka Y., Fredericks Z. L., Pitcher J. A., and Lefkowitz R. J.. 1997. Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J. Biol. Chem. 272:31051–31057.
   PubMed Web of Science ®Google Scholar
• Luttrell, L. M., Ferguson S. S. G., Daaka Y., Miller W. E., Maudsley S., Della Rocca G. J., Lin F. T., Kawakatsu H., Owada K., Luttrell D. K., Caron M. G., and Lefkowitz R. J.. 1999. Beta-arrestin-dependent formation of beta(2) adrenergic receptor Src protein kinase complexes. Science 283:655–661.
   PubMed Web of Science ®Google Scholar
• Luttrell, L. M., and Lefkowitz R. J.. 2002. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115:455–465.
   PubMed Web of Science ®Google Scholar
• Oakley, R. H., Laporte S. A., Holt J. A., Barak L. S., and Caron M. G.. 1999. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274:32248–32257.
   PubMed Web of Science ®Google Scholar
• Oakley, R. H., Laporte S. A., Holt J. A., Barak L. S., and Caron M. G.. 2001. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*. J. Biol. Chem. 276:19452–19460.
   PubMed Web of Science ®Google Scholar
• Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503–533.
   PubMed Web of Science ®Google Scholar
• Rice, K. M., Turnbow M. A., and Garner C. W.. 1993. Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 190:961–967.
   PubMedGoogle Scholar
• Ricort, J. M., Tanti J. F., Van Obberghen E., and Le Marchand-Brustel Y.. 1995. Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38:1148–1156.
   PubMed Web of Science ®Google Scholar
• Rui, L., Yuan M., Frantz D., Shoelson S., and White M. F.. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394–42398.
   PubMed Web of Science ®Google Scholar
• Rui, L. Y., Fisher T. L., Thomas J., and White M. F.. 2001. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J. Biol. Chem. 276:40362–40367.
   PubMedGoogle Scholar
• Shenoy, S. K., McDonald P. H., Kohout T. A., and Lefkowitz R. J.. 2001. Regulation of receptor fate by ubiquitination of activated beta(2)-adrenergic receptor and beta-arrestin. Science 294:1307–1313.
   PubMed Web of Science ®Google Scholar
• Smith, L. K., Vlahos C. J., Reddy K. K., Falck J. R., and Garner C. W.. 1995. Wortmannin and LY294002 inhibit the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes. Mol. Cell Endocrinol. 113:73–81.
   PubMedGoogle Scholar
• Sun, X. J., Goldberg J. L., Qiao L. Y., and Mitchell J. J.. 1999. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48:1359–1364.
   PubMedGoogle Scholar
• Takano, A., Usui I., Haruta T., Kawahara J., Uno T., Iwata M., and Kobayashi M.. 2001. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 21:5050–5062.
   PubMed Web of Science ®Google Scholar
• Usui, I., Imamura T., Huang J., Satoh H., and Olefsky J. M.. 2003. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 278:13765–13774.
   PubMed Web of Science ®Google Scholar
• Wang, P., Gao H., Ni Y. X., Wang B. B., Wu Y. L., Ji L. L., Qin L. H., Ma L., and Pei G.. 2003. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J. Biol. Chem. 278:6363–6370.
   PubMedGoogle Scholar
• Zhande, R., Mitchell J. J., Wu J., and Sun X. J.. 2002. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol. Cell. Biol. 22:1016–1026.
   PubMed Web of Science ®Google Scholar
• Zhang, H., Hoff H., and Sell C.. 2000. Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells. J. Biol. Chem. 275:22558–22562.
   PubMedGoogle Scholar